Article
The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, are potent BACH1…
medRxiv · 2021 · Casares, L.; Moreno, R.; Higgins, M.; Naidu, S. D.; Neill, G.; Cassin, L.; Kiib, A. E.; Svenningsen, E. B.; Honda, T.; Poulsen, T. B.; Dinkova-Kostova, A. T.; Olagnier, D.; de la Vega, L.
Key facts
| Title | The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, are potent BACH1 inhibitors |
|---|---|
| First author | Casares, L.; Moreno, R.; Higgins, M.; Naidu, S. D.; Neill, G.; Cassin, L.; Kiib, A. E.; Svenningsen, E. B.; Honda, T.; Poulsen, T. B.; Dinkova-Kostova, A. T.; Olagnier, D.; de la Vega, L. |
| Journal | medRxiv |
| Published | Oct 29, 2021 |
| DOI | 10.1101/2021.10.29.466411 |
| Devices mentioned | BK110039, K123955, K973350, K990827 |
| Product codes mentioned | JLX, KQP, OOI, PCA, KIT, MVU, NDS, NJT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1